A PotNetwork Special Report
Everyone will be trying to grab a piece of the Canadian cannabis market in the coming months, so watch out. PotNetwork put together this list of the top ten Canadian marijuana stocks to help you organize your portfolio in time for October 17.
Canopy Growth Corp.
Canopy Growth Corporation (TSX:WEED) (NYSE:CGC) acquired Hiku Brands recently to further diversify their portfolio. Combining their production capacity with Hiku’s distinct approach to retail cannabis could give Canopy the branding boost they need to outshine their competitors.
And Canopy Growth is looking beyond Canada’s recreational marijuana market. A recent agreement with Spectrum Cannabis Columbia brings Canopy Growth into its third Latin American country. Canopy Growth is now established in Columbia, Brazil, and Chile. As the largest cannabis company on the planet to date, Canopy Growth deserves a spot in your portfolio.
Aphria Inc. (TSX:APH) has their own plans for the South American market. On Tuesday, this marijuana stock announced expansion plans into Latin America and the Caribbean. Aphria acquired Scythian Biosciences Corp., giving the company exposure to over 300 million people across Colombia, Argentina, and Jamaica.
It is clear that Aphria is trying to establish itself as a cannabis leader on a global scale, and now they have access to a legal and regulated cannabis market that could reach into Brazil. This strategy could pay off big for investors, so it would be wise to watch this pot stock.
Aurora Cannabis Inc.
Aurora Cannabis (TSX:ACB) (OTCQB:ACBFF) is one pot stock known for making headlines. Their recent merger with MedReleaf is the largest cannabis deal to date. In fact, everything about Aurora Cannabis is big.
They have two production facilities slated to open this year. Aurora Sky, capable of producing 8000 kilograms of cannabis per month, will be harvesting bud at the end of July. And Aurora Vie in Quebec recently earned its license and will harvest cannabis by October.
Aurora Cannabis is more than ready to sell this much marijuana, too. They recruited Shopify on Tuesday to revamp the brand’s e-commerce platform to meet the global demand Aurora is anticipating over the coming months.
CannTrust Holdings Inc.
CannTrust Holdings Inc.’s (TSX:TRST) recent moves in both the medical and recreational cannabis markets earn them a spot in the top ten. For an investor looking for a diverse stock, you may want to consider CannTrust for their appeal to both cannabis markets.
To start with, CannTrust is investigating CBD oil’s effects on Lou Gehrig’s disease (ALS). And they scored recreational marijuana distribution deals in three provinces throughout Canada this month. Per the agreements, CannTrust will supply 17000 kilograms of cannabis to Alberta, Manitoba, and British Columbia by October.
Namaste Technologies Inc.
Namaste Technologies Inc. (TSXV:N) (OTC:NXTTF), with their high-tech approach to the cannabis industry, has a very competitive edge. In May, they acquired Findify, an artificial intelligence program, to improve their online patient portal, NamasteMD. The new tech will enrich the company’s data analytics so they can offer a more personalized shopping experience online.
NamasteMD already has 6000 registered patients, and that number is expected to grow. Namaste is looking globally and recently made an agreement with Israeli cannabis company Cannbit Ltd. This agreement brings Namaste’s telemedicine software to a market with “strong growth potential,” which is a good sign for investors following this marijuana stock.
The Cronos Group
The Cronos Group (NASDAQ:CRON) is the first cannabis company to uplist from the OTC exchange to the Nasdaq in the United States. Since then, this marijuana stock has been plowing ever forward.
The Cronos Group has a market cap of $1.2 billion, and over the past year, the company has earned nearly $5 million. Along with a strong presence in the medical marijuana market, Cronos teamed up with California natives MedMen Inc. to open new retail stores for the recreational market. The future looks bright for this pot stock, and investors can hear Cronos’ earnings and plans for the future during their conference call in August.
Organigram Holdings (TSXV:OGI) (OTCQB:OGRMF) won Sativa of the Year at last year’s Canadian Cannabis Awards with their Wabanaki strain. The winning weed is included in Organigram’s supply agreement with Hiku, which puts their products in dispensaries across Manitoba.
In a recent interview with The Motley Fool, Organigram CEO Greg Engel talks about the company’s precise expansion plan. This plan includes edibles and other infused products, something Organigram is turning to Colorado’s The Green Solution for help. Preparing for a market that will not be ready until October 2019 makes Organigram a smart stock to watch.
The Hydropothecary Corporation
The Hydropothecary Corporation (TSX:THCX) is among the 31 licensed producers tapped for cannabis supply agreements in British Columbia. In preparation for this and other recreational distribution agreements, the Hydropothecary unveiled its unique recreational cannabis brand, HEXO.
At the same time, they announced their application to uplist from the Toronto Venture Exchange. As of June 21, the marijuana stock is officially listed on the Toronto Stock Exchange (TSX). Things happen fast in this industry, and the quickness with which Hydropothecary is moving could be a sign that the time is now for an investment.
Emerald Health Therapeutics
Emerald Health Therapeutics (TSXV:EMH) (OTC:EMHTF) boasts an annual production capacity of 100,000 kilograms. Their joint venture with Village Farms International puts them at a solid 75,000 kilograms per year, but their new facility in Vancouver will easily push them over the 100,000 mark.
Even if their size does not yet compete with the likes of Canopy or Aurora, their agreement with Village Farms gives Emerald access to unique growing techniques and enhancements that could pay off big time for investors in the near future.
Tilray is the last on this list because they are one “marijuana stock” who is playing the game a little bit differently. Tilray may not be an official Canadian pot stock, but the cannabis company recently filed for a listing on the Nasdaq. The IPO was filed on June 20, with the company planning to share under the ticker TLRY.
Unfortunately, there is no official start date for this offering as of yet. But Tilray’s reputation as one of the first medical cannabis growers to receive a license from Health Canada, and their $1.3 billion valuation, makes them a strong bet as soon as the time is right.